Defunct Company
Total Trials
10
As Lead Sponsor
5
As Collaborator
Total Enrollment
2,416
NCT00307307
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
Phase: Phase 4
Role: Collaborator
Start: Jan 31, 2000
Completion: Sep 30, 2005
NCT00304993
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
Start: Jan 31, 2001
Completion: Feb 28, 2005
NCT00590629
Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women
Start: Jun 30, 2002
Completion: Nov 30, 2005
NCT00062556
Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2003
Completion: Mar 31, 2006
NCT00345657
Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
Start: Jul 31, 2003
Completion: May 31, 2004
NCT00071266
The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
Start: Oct 31, 2003
Completion: Not specified
NCT00080275
Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)
Start: Mar 31, 2004
NCT00079638
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
Start: Apr 30, 2004
Completion: May 31, 2005
NCT00300365
Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL
Phase: Phase 2
Start: Nov 30, 2005
Completion: Aug 31, 2010